News Allergan ‘not looking for big deals’ as growth slows Company will put its $27 billion to use, however
News Merck, Allergan named as potential bidders for Biogen Biogen vulnerable to takeover as chief executive steps down
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
